Brief: Scandinavian Chemotech Gets Final Patent Approval In EU For Tumour Specific Control Unit
May 17 (Reuters) - Scandinavian ChemoTech AB CMOTECb.ST :
* RECEIVES FINAL PATENT APPROVAL IN THE EU FOR THE TUMOUR
SPECIFIC
CONTROL UNIT IN OUR TSE™ PLATFORM
Source text for Eikon: ID:nWkrb23QW6
Further company coverage: CMOTECb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million